Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pharmaceutical science, The Journal and you

Pharmacy is a scientific profession. That is the solid reminder in the Royal Pharmaceutical Society’s report “New medicines, better medicines, better use of medicines”, published this week. The guide describes the spectrum of basic, applied and social sciences involved in bringing medicines to patients and ensuring their safe and effective use.

At 119 pages, the report might appear too hefty to consume in one sitting, but then it does provide a comprehensive overview of how pharmacy and pharmaceutical science intertwine. And it is easy to digest, written in a way that highlights the complexity of the drug development process without losing to jargon anyone who does not happen to have a science degree. The Journal is aware that years of collaborative working have gone into producing the final document — which represents the views of the RPS’s independent Pharmaceutical Science Expert Advisory Panel.

Its recommendations — summarised in the infographic that accompanies our News feature — are broad and, The Journal believes, send out a strong message to policy-makers and other non-pharmacy stakeholders as to the importance of pharmaceutical professionals. The document should serve the RPS well as it seeks to grow its pharmaceutical scientist membership.

It also fits with The Pharmaceutical Journal’s vision. We will be making use of the guide to inform the direction of our science and research coverage, which we have started to enhance in response to feedback as part of our 2014 editorial strategy. You may have seen a notable output of this strategy last week: our News feature on nanomedicine (PJ 2014;292:467).

As described by the expert advisory panel chairman in an Agenda, the scientific enquiry that is the bedrock of pharmaceutical practice (in all the stages a medicine proceeds from the laboratory through to the clinic) should be championed by pharmacists and pharmaceutical scientists alike. The Journal is here to support that ambition, and we look forward to using “New medicines, better medicines, better use of medicines” as a source of inspiration in 2014 and beyond.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.11138200

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.